Secretor genotype (FUT2 gene) is strongly associated with the composition of bifidobacteria in the human intestine

PLoS ONE

Volumn 6, Issue 5, 2011, Pages

  Wacklin, Pirjo ^a   Mäkivuokko, Harri ^a   Alakulppi, Noora ^a   Nikkilä, Janne ^a   Tenkanen, Heli ^a   Räbinä, Jarkko ^a   Partanen, Jukka ^a   Aranko, Kari ^a   Mättö, Jaana ^a  

^a FINNISH RED CROSS BLOOD SERVICE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD GROUP ABH ANTIGEN; BLOOD GROUP ANTIGEN; FUCOSYLTRANSFERASE; FUCOSYLTRANSFERASE 2; LEWIS HISTO BLOOD GROUP ANTIGEN; UNCLASSIFIED DRUG; GALACTOSIDE 2 ALPHA L FUCOSYLTRANSFERASE; GALACTOSIDE 2-ALPHA-L-FUCOSYLTRANSFERASE;

ADULT; ARTICLE; BACTERIAL GENE; BIFIDOBACTERIUM; BIFIDOBACTERIUM ADOLESCENTIS; BIFIDOBACTERIUM BIFIDUM; BIFIDOBACTERIUM CATENULATUM; BIFIDOBACTERIUM PSEUDOCATENULATUM; CONTROLLED STUDY; DENATURING GRADIENT GEL ELECTROPHORESIS; FECES ANALYSIS; FEMALE; FUCOSYLTRANSFERASE 2 GENE; GENOTYPE; HUMAN; HUMAN TISSUE; INTESTINE; MALE; MICROBIAL DIVERSITY; NONHUMAN; NONSENSE MUTATION; PHENOTYPE; POLYMERASE CHAIN REACTION; POPULATION ABUNDANCE; GENETICS; ISOLATION AND PURIFICATION; MICROBIOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS;

BACTERIA (MICROORGANISMS);

BIFIDOBACTERIUM; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FUCOSYLTRANSFERASES; GENOTYPE; HUMANS; INTESTINES; POLYMERASE CHAIN REACTION;

EID: 79956257405     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0020113     Document Type: Article

References (50)

1. Round JL, Mazmanian SK, (2009) The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol 9 (5): 313-323.
2. Backhed F, Ding H, Wang T, Hooper LV, Koh GY, et al. (2004) The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A 101 (44): 15718-15723.
3. Turnbaugh PJ, Ley RE, Hamady M, Fraser-Liggett CM, Knight R, et al. (2007) The human microbiome project. Nature 449 (7164): 804-810.
4. Ley RE, Turnbaugh PJ, Klein S, Gordon JI, (2006) Microbial ecology: Human gut microbes associated with obesity. Nature 444 (7122): 1022-1023.
5. De Filippo C, Cavalieri D, Di Paola M, Ramazzotti M, Poullet JB, et al. (2010) Impact of diet in shaping gut microbiota revealed by a comparative study in children from europe and rural africa. Proc Natl Acad Sci U S A 107 (33): 14691-14696.
6. Zoetendal EG, Akkermans ADL, Akkermans-van Vliet WM, de Visser, Arjan G. M J, et al. (2001) The host genotype affects the bacterial community in the human gastronintestinal tract. Microbial Ecology in Health and Disease 13 (3): 129-134.
7. Rajilic-Stojanovic M, (2007) Diversity of human gastrointestinal microbiota. novel perspestives from high throughput analyses PhD thesis, WageningenUniveristy and Research Center: Wageningen pp. 214 p.
8. Turnbaugh PJ, Hamady M, Yatsunenko T, Cantarel BL, Duncan A, et al. (2009) A core gut microbiome in obese and lean twins. Nature 457 (7228): 480-484.
9. Lay C, Rigottier-Gois L, Holmstrom K, Rajilic M, Vaughan EE, et al. (2005) Colonic microbiota signatures across five northern european countries. Appl Environ Microbiol 71 (7): 4153-4155.
10. Mättö J, Malinen E, Suihko ML, Alander M, Palva A, et al. (2004) Genetic heterogeneity and functional properties of intestinal bifidobacteria. J Appl Microbiol 97 (3): 459-470.
11. Matsuki T, Watanabe K, Tanaka R, Fukuda M, Oyaizu H, (1999) Distribution of bifidobacterial species in human intestinal microflora examined with 16S rRNA-gene-targeted species-specific primers. Appl Environ Microbiol 65 (10): 4506-4512.
12. Turroni F, Marchesi JR, Foroni E, Gueimonde M, Shanahan F, et al. (2009) Microbiomic analysis of the bifidobacterial population in the human distal gut. ISME J 3 (6): 745-751.
13. Boesten RJ, de Vos WM, (2008) Interactomics in the human intestine: Lactobacilli and bifidobacteria make a difference. J Clin Gastroenterol 42 Suppl 3 Pt 2: S163-7.
14. Hoskins LC, Agustines M, McKee WB, Boulding ET, Kriaris M, et al. (1985) Mucin degradation in human colon ecosystems. isolation and properties of fecal strains that degrade ABH blood group antigens and oligosaccharides from mucin glycoproteins. J Clin Invest 75 (3): 944-953.
15. Moulds JM, Nowicki S, Moulds JJ, Nowicki BJ, (1996) Human blood groups: Incidental receptors for viruses and bacteria. Transfusion 36 (4): 362-374.
16. Linden S, Mahdavi J, Semino-Mora C, Olsen C, Carlstedt I, et al. (2008) Role of ABO secretor status in mucosal innate immunity and H. pylori infection. PLoS Pathog 4 (1): e2.
17. Anstee DJ, (2010) The relationship between blood groups and disease. Blood 115 (23): 4635-4643.
18. McGovern DP, Jones MR, Taylor KD, Marciante K, Yan X, et al. (2010) Fucosyltransferase 2 (FUT2) non-secretor status is associated with crohn's disease. Hum Mol Genet 19 (17): 3468-3476.
19. Franke A, McGovern DP, Barrett JC, Wang K, Radford-Smith GL, et al. (2010) Genome-wide meta-analysis increases to 71 the number of confirmed crohn's disease susceptibility loci. Nat Genet 42 (12): 1118-1125.
20. Morrow AL, Meinzen-Derr J, Huang P, Schibler KR, Cahill T, et al. (2010) Secretor phenotype and genotype are novel predictors of severe outcomes in premature infants. FASEB J 24(1_MeetingAbstracts) pp. 480.6.
21. Kinane DF, Blackwell CC, Brettle RP, Weir DM, Winstanley FP, et al. (1982) ABO blood group, secretor state, and susceptibility to recurrent urinary tract infection in women. Br Med J (Clin Res Ed) 285 (6334): 7-9.
22. Sheinfeld J, Schaeffer AJ, Cordon-Cardo C, Rogatko A, Fair WR, (1989) Association of the lewis blood-group phenotype with recurrent urinary tract infections in women. N Engl J Med 320 (12): 773-777.
23. Thorn SM, Blackwell CC, MacCallum CJ, Weir DM, Brettle RP, et al. (1989) Nonsecretion of ABO blood group antigens and susceptibility to infection by candida species. FEMS Microbiology Immunology 47: 401-406.
24. Hurd EA, Domino SE, (2004) Increased susceptibility of secretor factor gene Fut2-null mice to experimental vaginal candidiasis. Infect Immun 72 (7): 4279-4281.
25. Larsson MM, Rydell GE, Grahn A, Rodriguez-Diaz J, Akerlind B, et al. (2006) Antibody prevalence and titer to norovirus (genogroup II) correlate with secretor (FUT2) but not with ABO phenotype or lewis (FUT3) genotype. J Infect Dis 194 (10): 1422-1427.
26. Seksik P, Rigottier-Gois L, Gramet G, Sutren M, Pochart P, et al. (2003) Alterations of the dominant faecal bacterial groups in patients with crohn's disease of the colon. Gut 52 (2): 237-242.
27. Willing B, Halfvarson J, Dicksved J, Rosenquist M, Jarnerot G, et al. (2009) Twin studies reveal specific imbalances in the mucosa-associated microbiota of patients with ileal crohn's disease. Inflamm Bowel Dis 15 (5): 653-660.
28. Kirjavainen PV, Pautler S, Baroja ML, Anukam K, Crowley K, et al. (2009) Abnormal immunological profile and vaginal microbiota in women prone to urinary tract infections. Clin Vaccine Immunol 16 (1): 29-36.
29. Wang Y, Hoenig JD, Malin KJ, Qamar S, Petrof EO, et al. (2009) 16S rRNA gene-based analysis of fecal microbiota from preterm infants with and without necrotizing enterocolitis. ISME J 3 (8): 944-954.
30. Brenner DM, Chey WD, (2009) Bifidobacterium infantis 35624: A novel probiotic for the treatment of irritable bowel syndrome. Rev Gastroenterol Disord 9 (1): 7-15.
31. Macfarlane GT, Blackett KL, Nakayama T, Steed H, Macfarlane S, (2009) The gut microbiota in inflammatory bowel disease. Curr Pharm Des 15 (13): 1528-1536.
32. Chouraqui JP, Van Egroo LD, Fichot MC, (2004) Acidified milk formula supplemented with bifidobacterium lactis: Impact on infant diarrhea in residential care settings. J Pediatr Gastroenterol Nutr 38 (3): 288-292.
33. Malinen E, Rinttilä T, Kajander K, Mättö J, Kassinen A, et al. (2005) Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR. Am J Gastroenterol 100 (2): 373-382.
34. Kurokawa K, Itoh T, Kuwahara T, Oshima K, Toh H, et al. (2007) Comparative metagenomics revealed commonly enriched gene sets in human gut microbiomes. DNA Res 14 (4): 169-181.
35. Bry L, Falk PG, Midtvedt T, Gordon JI, (1996) A model of host-microbial interactions in an open mammalian ecosystem. Science 273 (5280): 1380-1383.
36. Hooper LV, Gordon JI, (2001) Glycans as legislators of host-microbial interactions: Spanning the spectrum from symbiosis to pathogenicity. Glycobiology 11 (2): 1R-10R.
37. Turroni F, van Sinderen D, Ventura M, (2009) Bifidobacteria: From ecology to genomics. Front Biosci 14: 4673-4684.
38. Katayama T, Sakuma A, Kimura T, Makimura Y, Hiratake J, et al. (2004) Molecular cloning and characterization of bifidobacterium bifidum 1,2-alpha-L-fucosidase (AfcA), a novel inverting glycosidase (glycoside hydrolase family 95). J Bacteriol 186 (15): 4885-4893.
39. Turroni F, Bottacini F, Foroni E, Mulder I, Kim JH, et al. (2010) Genome analysis of bifidobacterium bifidum PRL2010 reveals metabolic pathways for host-derived glycan foraging. Proc Natl Acad Sci U S A 107 (45): 19514-19519.
40. Wada J, Ando T, Kiyohara M, Ashida H, Kitaoka M, et al. (2008) Bifidobacterium bifidum lacto-N-biosidase, a critical enzyme for the degradation of human milk oligosaccharides with a type 1 structure. Appl Environ Microbiol 74 (13): 3996-4004.
41. Silva LM, Carvalho AS, Guillon P, Seixas S, Azevedo M, et al. (2010) Infection-associated FUT2 (fucosyltransferase 2) genetic variation and impact on functionality assessed by in vivo studies. Glycoconj J 27 (1): 61-68.
42. Ferrer-Admetlla A, Sikora M, Laayouni H, Esteve A, Roubinet F, et al. (2009) A natural history of FUT2 polymorphism in humans. Mol Biol Evol 26 (9): 1993-2003.
43. Nübel U, Engelen B, Felske A, Snaidr J, Wieshuber A, et al. (1996) Sequence heterogeneities of genes encoding 16S rRNAs in paenibacillus polymyxa detected by temperature gradient gel electrophoresis. J Bacteriol 178 (19): 5636-5643.
44. Mättö J, Maunuksela L, Kajander K, Palva A, Korpela R, et al. (2005) Composition and temporal stability of gastrointestinal microbiota in irritable bowel syndrome-a longitudinal study in IBS and control subjects. FEMS Immunol Med Microbiol 43 (2): 213-222.
45. Satokari RM, Vaughan EE, Akkermans AD, Saarela M, de Vos WM, (2001) Bifidobacterial diversity in human feces detected by genus-specific PCR and denaturing gradient gel electrophoresis. Appl Environ Microbiol 67 (2): 504-513.
46. Thompson JD, Gibson TJ, Higgins DG, (2002) Multiple sequence alignment using ClustalW and ClustalX. Curr Protoc Bioinformatics Chapter 2: Unit 2.3.
47. Ferrer-Admetlla A, Sikora M, Laayouni H, Esteve A, Roubinet F, et al. (2009) A natural history of FUT2 polymorphism in humans. Mol Biol Evol 26 (9): 1993-2003.
48. Tseng CP, Cheng JC, Tseng CC, Wang C, Chen YL, et al. (2003) Broad-range ribosomal RNA real-time PCR after removal of DNA from reagents: Melting profiles for clinically important bacteria. Clin Chem 49 (2): 306-309.
49. Rinttilä T, Kassinen A, Malinen E, Krogius L, Palva A, (2004) Development of an extensive set of 16S rDNA-targeted primers for quantification of pathogenic and indigenous bacteria in faecal samples by real-time PCR. J Appl Microbiol 97 (6): 1166-1177.
50. Matsuki T, Watanabe K, Fujimoto J, Kado Y, Takada T, et al. (2004) Quantitative PCR with 16S rRNA-gene-targeted species-specific primers for analysis of human intestinal bifidobacteria. Appl Environ Microbiol 70 (1): 167-173.